Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-07-11
2006-07-11
Yu, Misook (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S389100
Reexamination Certificate
active
07074902
ABSTRACT:
An isolated and purified DNA molecule encoding a DNA repair protein, p95, is provided, as is isolated and purified p95. Also provided are methods of detecting p95 and DNA encoding p95. The invention further provides p95 knock-out mice.
REFERENCES:
patent: 5965427 (1999-10-01), Dolganov et al.
patent: 6458534 (2002-10-01), Concannon et al.
patent: 6479237 (2002-11-01), Camonis et al.
patent: WO-98/07030 (1998-02-01), None
patent: WO-98/41648 (1998-09-01), None
Allemand, I., et al., “Transgenic and Knock-Out Models for Studying DNA Repair”,Biochimie,77, 826-832, (1995).
Baldwin, et al.,Monoclonal Antibodies for Cancer Detection and Therapy,20, (1985).
Brandon, E.P., et al., “Targeting the Mouse Genome: A Compendium of Knockouts (Part I)”,Current Biology,5, 625-634, (1995).
Brandon, E.P., et al., “Targeting the Mouse Genome: A Compendium of Knockouts (Part II)”,Current Biology,5, 758-765, (1995).
Choi, I.S., et al., “Expression of RAD4 gene ofSaccharomyces cerevisiaethat can be propagated inEscherichia coliwithout inactivation”,Biochemical and Biophysical Research Communications,vol. 193 (1), 191-197, May 28, 1993.
de Vries, A., et al., “Xpa Knockout Mice”,Seminars in Cancer Biology,7, 229-240, (1996).
Dolganov, G.M., et al., “Human Rad50 Is Physically Associated with Human Mrell: Identification of a Conserved Multiprotein Complex Implicated in Recombinational DNA Repair”,Molecular and Cellular Biology,16, 4832-4841, (Sep. 1996).
Majzoub, J.A., et al., “Knockout Mice”,The New England Journal of Medicine,334, 904-907, (Apr. 4, 1996).
Maser, R.S., et al., “hMrell and hRad50 Nuclear Foci Are Induced during the Normal Cellular Response to DNA Double-Strand Breaks”,Molecular and Cellular Biology,17, 6087-6096, (Oct. 1997).
Nicolaides, N.C., et al., “Analysis of the 5′ region of PMS2 reveals heterogeneous transcripts and a novel overlapping gene”,Genomics,29, 329-334 , (1997).
Petrini, J.H., et al., “Isolation and characterizatio of the human MRE11 homologue”,Genomics,29, 80-86, (1995).
Rosenberg, M.P., “Gene Knockout and Transgenic Technologies in Risk Assessment: The Next Generation”,Molecular Carcinogenesis,20, 262-274, (1997).
Xiao, Y., et al., “Conditional gene targeted deletion by Cre recombinase demonstrates the requirement for the double-strand break repair Mrell protein in murine embryonic stem cells”,Nucleid Acids Research,vol. 25, 15, 2985-2991, (1997).
Carney, James P., et al., “The hMre11/hRad50 Protein Complex and Nijmegen Breakage Syndrome: Linkage of Double-Strand Break Repair to the Cellular DNA Damage Response”,Cell, 93,(May 1, 1998), 477-486.
Lim, Dae-Sik , et al., “ATM Phosphorylates p95
bs1 in an S-phase Checkpoint Pathway”,Nature,vol. 404, (Apr. 6, 2000), 613-617.
Eck, S. L., et al., “Gene-Based Therapy”,In: Goodman and Gilman's The Pharmacological Basis of Therapeutics, Ninth Edition,Chapter 5, McGraw-Hill, Health Professions Division, New York, (1996), 77-101.
Houdebine, L., “Production of Pharmaceutical Proteins From Transgenic Animals”,Journal of Biotechnology,vol. 34, France, (1994), 269-287.
Orkin, S. H., et al., “Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy”, National Institutes of Health, Entire Document, (Dec. 7, 1995), 40 pages.
Verma, I. M., et al., “Gene Therapy Promises, Proboems and Prospects”,Nature,vol. 389, (Sep. 18, 1997), 239-242.
Nockoloff, et al., “DNA Damage and Repair”, vol. 2, (1998), 335-393.
NCBI(AA577530), www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=nucleotide&list—uids=...,(1997),2.
NCBI(AA535711), www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=nucleotide&list—uids=..., (1997),2.
Varon, R., et al., “Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome”,Cell Press,93, (May 1, 1998),467-476.
Carney James Patrick
Maser Richard Scott
Morgan William Francis
Petrini John H. J.
Schwegman Lundberg Woessner & Kluth P.A.
University of California
WARF Wisconsin Alumni Research Foundation
Yu Misook
LandOfFree
Antibody specific for a DNA repair protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody specific for a DNA repair protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody specific for a DNA repair protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3575692